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Abstract
Background: Numerous surveys have shown that orthodontic mini implants (OMIs) are underused in clinical
practice. To investigate this implementation issue, we conducted a systematic review to (1) identify barriers and
facilitators to the implementation of OMIs for all potential stakeholders and (2) quantify these implementation
constructs, i.e., record their prevalence. We also recorded the prevalence of clinicians in the eligible studies that
do not use OMIs.
Methods: Methods were based on our published protocol. Broad-spectrum eligibility criteria were defined. A
barrier was defined as any variable that impedes or obstructs the use of OMIs and a facilitator as any variable that
eases and promotes their use. Over 30 databases including gray literature were searched until 15 January 2016.
The Joanna Briggs Institute tool for studies reporting prevalence and incidence data was used to critically appraise the
included studies. Outcomes were qualitatively synthesized, and meta-analyses were only conducted when pre-set
criteria were fulfilled. Three reviewers conducted all research procedures independently. We also contacted authors
of eligible studies to obtain additional information.
Results: Three surveys fulfilled the eligibility criteria. Seventeen implementation constructs were identified in these
studies and were extracted from a total of 165 patients and 1391 clinicians. Eight of the 17 constructs were scored by
more than 50 % of the pertinent stakeholders. Three of these constructs overlapped between studies. Contacting of
authors clarified various uncertainties but was not always successful. Limitations of the eligible studies included (1) the
small number of studies; (2) not defining the research questions, i.e., the primary outcomes; (3) the research design
(surveys) of the studies and the exclusive use of closed-ended questions; (4) not consulting standards for identifying
implementation constructs; (5) the lack of pilot testing; (6) high heterogeneity; (7) the risk of reporting bias; and (8)
additional shortcomings. Meta-analyses were not possible because of these limitations. Two eligible studies found that
respectively 56.3 % (952/1691) and 40.16 % (439/1093) of clinicians do not use OMIs.
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Conclusions: Notwithstanding the limitations of the eligible studies, their findings were important because (1)
17 implementation constructs were identified of which 8 were scored by more than 50 % of the stakeholders;
(2) the various shortcomings showed how to improve on future implementation studies; and (3) the underuse
of OMIs in the selected studies and in the literature demonstrated the need to identify, quantify, and address
implementation constructs. Prioritizing of future research questions on OMIs with all pertinent stakeholders is
an important first step and could redirect research studies on OMIs towards implementation issues. Patients,
clinicians, researchers, policymakers, insurance companies, implant companies, and research sponsors will all
be beneficiaries.
Keywords: Mini implant, Screw, Orthodontics, Implementation, Knowledge translation, Barriers, Facilitators,
Contacting authors, Systematic review
Background
Getting effective healthcare innovations into practice is
often suboptimal [1–3]. This implementation issue also
applies to orthodontic mini implants (OMIs) because
surveys worldwide have shown that many clinicians
rarely or never use these devices [4–8] notwithstanding
their promising success rates, effectiveness, and applic-
ability [9–11]. To understand the causes of this problem,
it is important to identify the barriers and facilitators to
the implementation of OMIs in clinical practice. This
systematic review identified and quantified these imple-
mentation constructs.
Most orthodontic treatment plans need some form of
anchorage to counteract the reciprocal forces of ortho-
dontic tooth movement [12]. Numerous anchorage
systems have been developed for this purpose. They
generally apply forces to groups of teeth or use extra-
oral traction to the neck or cranium. These techniques
are effective, but they can still cause a loss of anchorage,
have a limited area of application, and often depend on
the constant collaboration of the patient [12]. OMIs are
not limited by most of these characteristics; they can be
implemented in a wide variety of orthodontic treatment
plans and can be used in the maxilla and mandible for
long periods of time [10]. The most frequently used
OMIs are machine surfaced bone screws with a diameter
of 1.3–2 mm and a length of 6–10 mm [11]. Both single
and multiple OMIs with or without connecting plates
are used for anchorage purposes. After insertion, OMIs
are usually loaded immediately with orthodontic forces,
and they are removed after the completion of the ortho-
dontic treatment objectives.
Since the introduction of OMIs in 1997 by Kanomi
[13], the number of publications on these devices has
increased exponentially [14] and systematic reviews on
OMIs have recorded promising low implant failure rates
[11, 15] and favorable effectiveness [9, 10]. Numerous
orthodontic companies have been founded and presenta-
tions of orthodontic treatments with OMIs have become
the norm at orthodontic meetings [16]. International
orthodontic conferences are even organized that focus
exclusively on treatment with OMIs [17].
However, surveys in the USA, India, Germany, and
England showed that many orthodontists never or rarely
use these devices [4–8, 18–20]. This knowledge-to-
action (KTA) gap, which is the gap between evidence-
based knowledge and the use of this information in
practice, was unexpected for a technique that has been
introduced almost 20 years ago and has received such
high acclaims [3, 9–11, 13]. This KTA gap was also
unexpected in the context that most orthodontic treat-
ment plans need some form of anchorage [12]. In
addition, more than 75 % of 108 surveyed doctors
included OMIs in their treatment plan for a common
orthodontic patient [21].
KTA gaps are not just limited to interventional proce-
dures with OMIs but are common for a variety of
medical conditions and are a global problem [22, 23].
Only a small fraction of healthcare innovations gets
incorporated into practice, and it has been estimated
that 45 % of patients in the USA do not receive recom-
mended care [23, 24]. In recent years, interest in the
causes of KTA gaps and strategies for dealing with them
has increased dramatically [25]. Identifying and quantify-
ing implementation constructs of healthcare interven-
tions is an important step to address these issues.
We therefore developed a systematic review that iden-
tified and quantified barriers and facilitators to the
implementation of OMIs in clinical practice. We applied
this primary research objective to both demand-side
stakeholders, i.e., orthodontic patients and their family
members, and potential supply-side stakeholders, e.g.,
clinicians, office staff, clinic owners, researchers, guide-
line developers, policy makers, and implant companies.
Barriers to the implementation of OMIs could refer to
the invasiveness of the interventional procedure, learn-
ing a new technique, the adverse effects of interventions
and the fear of complications, financial barriers, the
large volume of research evidence, the lack of trust in
research evidence, the applicability of the new health
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technology to a local context, etc. [5, 8, 26–28]. Facilita-
tors to implementation of OMIs could refer to shorter
treatment time, better outcomes, improved esthetics
during orthodontic treatment, recommendations by
patients who had undergone treatment with OMIs, etc.
[5, 29, 30]. Research data on the identified and quantified
implementation constructs can be subsequently consulted
to develop tailored strategies to deal with them.
For our secondary objectives, we recorded the preva-
lence of clinicians that do not use OMIs in clinical prac-
tice. This statistic was extracted from the studies that
were identified as “eligible” for our primary research ques-
tion. During our scoping searches, we identified no sys-
tematic reviews that addressed our primary and secondary
research questions on the implementation of OMIs.
Objectives
The following objectives of this systematic review were
defined:
Primary objective
 To identify and quantify barriers and facilitators to
the implementation of OMIs for all potential
stakeholders such as patients and their family
members, clinicians, office staff, clinic owners,
researchers, guideline developers, policy makers, and
implant companies.
Secondary objective
 To record the prevalence of clinicians that do not
use OMIs in the studies that were selected for the
primary objectives. This statistic represents the
knowledge-to-action gap for these stakeholders.
Methods
We applied the methods that were described previously in
our published protocol [14]. Various sources were con-
sulted to develop these methods: (1) established concep-
tual models for assessing barriers and facilitators to the
implementation of knowledge use [22, 25, 26, 31, 32]; (2)
guidelines and handbooks for designing and reporting
qualitative and quantitative systematic reviews [33–38];
(3) guidelines and checklists for reporting research studies
[39]; (4) systematic reviews that were specifically designed
to identify implementation constructs and addressed
similar research objectives as our research study [27, 28,
40–44]; and (5) systematic reviews and their protocols on
OMIs that we have published previously [14, 45–48].
The characteristics and application of these sources
are further explained in the pertinent sections of this
systematic review. Differences between our protocol and
the final systematic review are reported in the “Results”
section together with the rationale and the consequences
of these modifications. We adopted the PRISMA 2009
Statement for reporting systematic reviews and pre-
sented this manuscript according to the order of this
guideline (Additional file 1)[36, 49]. This systematic
review was not registered in the PROSPERO database
because our research questions are not covered by the
inclusion criteria of this register [50].
Eligibility criteria
We applied the eligibility criteria that were outlined in
our published protocol [14]. These criteria are summa-
rized under here.
Study designs
For the primary objectives, we defined the following
eligibility criteria:
 Studies that collected original data on identified
barriers and facilitators to the implementation of
OMIs in clinical practice were eligible. To avoid
exclusion of pertinent studies, we did not set
eligibility criteria for specific research designs. We
expected to find interviews, focus groups, surveys,
and questionnaires as the most common eligible
research designs.
 Studies that addressed our primary research
question as their primary or secondary objectives
were eligible. For example, studies that identified
barriers and facilitators to the implementation of
OMIs in clinical practice as a part of a larger mixed
methods model were eligible.
For the secondary objectives, we defined the following
eligibility criteria:
 Only quantitative studies, for example, surveys, that
addressed the primary objectives of this systematic
review were eligible.
Stakeholders (participants)
We applied broad-spectrum selection criteria that included
all potential demand- and supply-side stakeholders. The
former category refers to patients undergoing the interven-
tional procedure and the pertinent family members. The
latter category refers to the following stakeholders: clini-
cians, clinic owners, researchers, office staff, guideline
developers, policy makers, and implant companies.
Interventions
Interventions that used single or multiple implants with
diameters smaller than 2.5 mm for orthodontic anchor-
age objectives were eligible. We applied no restrictions
to the length or design of the implant, its connection to
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plates, its location of insertion, the type of method for
implant insertion, the type of orthodontic loading, and
the type of implant maintenance after its insertion.
Interventions with OMIs on patients of any age, sex, or
demographics were eligible.
Outcomes
Any type of barrier or facilitator to the use of OMIs in clin-
ical practice was selected as our primary outcome. A barrier
was defined as any variable that impedes or obstructs their
use. A facilitator was defined as any variable that eases and
promotes the use of OMIs. Barriers and facilitators were
eligible when they were described as implementation
constructs by the eligible stakeholders [44]. For example,
patient’s perceptions of the interventional procedure or
assessments of health experiences such as pain and discom-
fort during implant insertion were not considered as
eligible outcomes when they were not specifically defined
as barriers to the use of OMIs by these patients. These
eligibility criteria avoid mislabelling of implementation
constructs during qualitative analyses as a result of bias or
misinterpretation of outcomes by systematic reviewers.
Setting and language
No setting and language restrictions were applied.
Information sources and search
Information sources were searched from 1 January 1997,
the year of the first publication on OMIs, until 15
January 2016 [13].
 The following general and subject-specific electronic
databases were searched: Google Scholar Beta,
PubMed (MEDLINE), EMBASE (Ovid), Cochrane
Central Register of Controlled Trials (CENTRAL),
CINAHL, PsycINFO, Sociological Abstracts, and
PROSPERO [51–55].
 The “Related Articles” feature in PubMed was
consulted.
 The following Web of Science Core collection
citation indexes were searched: Science Citation
Index Expanded (SCI-EXPANDED); ARTS and
Humanities Citation Index (A&HCI); and Social
Sciences Citation Index (SSCI) [53, 56, 57].
 A series of national and regional databases was
also searched: African Index Medicus, African
Journals online (AJOL), Informit Health
Collection, Index Medicus for the Eastern
Mediterranean Region, IndMED, KoreaMed,
LILACS, Index Medicus for the South-East Asia
Region (IMSEAR), Western Pacific Region Index
Medicus (WPRIM) [53, 56].
 We also consulted “other resources” which included
the gray literature, reference lists, and hand-searches
of key journals. A detailed list of these resources was
presented in our published protocol [14].
 We also contacted pertinent stakeholders on our
topic of interest.
Methods to find pertinent subject headings and key
words were adopted from our previous systematic reviews
and protocols on OMIs [14, 45–48]. An information
specialist (NR) in computerized searches of healthcare
publications assisted with the development of the search
strategies. In our protocol, we presented the full electronic
search strategies for both PubMed and Google Scholar Beta
[14]. For PubMed, we used the following search strategy:
(orthodontics OR orthodontic OR orthodontist OR ortho-
dontists) (implant OR implants OR “mini implant” OR
“mini implants” OR screw OR screws OR “mini screw” OR
“mini screws” OR “miniscrew” OR “miniscrews” OR
“microscrew” OR “temporary anchorage device”).
Study selection
Eligible studies for this systematic review were selected
independently by three review authors (RMR, LR, and LL).
Disagreements between these operators on the eligibility of
an article were resolved through rereading of the pertinent
article, discussions, and if necessary through contacting its
authors [49]. In the case of persistent disagreements, a
fourth author (NDG) was asked to arbiter.
The selection of studies was summarized in a PRISMA
flow diagram [36, 49]. Excluded articles were listed in a
table with the reasons for their exclusion. A detailed
description of the procedures for selecting studies,
contacting authors, and for assessing multiple publica-
tions of the same research data and dealing with these
issues were presented in our published protocol [14]. All
study selection procedures were conducted according to
this protocol.
Data collection process and data items
Prior to the formal study selection and data extraction
process, a list of “potential” barriers and facilitators to
the implementation of OMIs was developed by the three
reviewers (RMR, LR, and LL). This list was developed
through the assessment and discussions of three groups
of publications: (1) systematic reviews that focused on
the identification of barriers and facilitators to the
implementation of health-related issues and technologies
[27, 28, 40–44]; (2) conceptual models for assessing bar-
riers and facilitators to knowledge use [25, 26, 31, 32,
58]; and (3) our previous systematic reviews and proto-
cols on OMIs [14, 45–48]. This list of “potential” bar-
riers and facilitators was created prior to the study
selection and data extraction process and was used to
calibrate the three reviewers and to increase their back-
ground knowledge on implementation constructs. Our
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list of “potential” implementation constructs was not
used as a reference checklist during the study selection
and data collection process because this could have re-
sulted in the inappropriate exclusion of “unexpected”
barriers and facilitators to the implementation of OMIs
in clinical practice.
For the development of the data collection forms, we
explored (1) the reporting checklists of pertinent
research designs of the Equator network [39]; (2) the
data extraction forms of previous systematic reviews and
protocols on OMIs [14, 45–48]; and (3) the three groups
of publications that were used to develop the list of
potential implementation constructs [25–28, 31, 32, 40–
48, 58]. Pertinent items for the extraction of data for the
secondary research question were also assessed during
this research phase. Extracted data items for our primary
and secondary objectives include: the source, eligibility,
duplicate publication, the study design, selection proce-
dures, stakeholders, the setting, interventions, outcomes,
flow and timing, adverse effects, withdrawals and
missing outcomes, the funding, and miscellaneous data
of the selected studies [36, 38]. Many of these items
were further subdivided and all extracted entries were
listed in tables. Descriptions of each item were presented
in these tables and entries that could bias the outcomes
were also recorded.
All data extraction procedures were conducted inde-
pendently by the three aforementioned operators, who
are experienced systematic reviewers and topic experts.
Disagreements on extracted items were resolved through
rereading and discussions and if necessary an arbitrator
(NDG) was consulted to adjudicate these disagreements.
Our pilot-tested data extraction forms and a detailed de-
scription of our data collection procedures were given in
the published protocol of this systematic review [14].
Outcomes and prioritization
Primary outcomes
 The primary outcomes were all barriers and
facilitators to the implementation of OMIs in
clinical practice identified by all demand-and sup-
ply-side stakeholders. When given, we recorded
also the prevalence of implementation constructs
among subgroups of pertinent stakeholders.
 Pertinent stakeholders were defined in Table 1 and
were divided in “users” and “non-users.” Potential
subgroups for which outcomes were recorded are
presented in Table 1.
 A barrier is defined as any variable that impedes or
obstructs the use of OMIs. A facilitator is defined as
any variable that eases and promotes their use.
 The pre-intervention recording of barriers or
facilitators to a “specified” intervention with OMIs
for “non-user” clinicians or for patients that have
not undergone this intervention previously in any
type of setting or research design was our
“preferred” primary outcome.
Table 1 Potential subgroups for which outcomes were recorded
General subgroups Specific subgroups
Research design Surveys: outcomes obtained through surveys (questionnaires) of stakeholders
Interviews: outcomes obtained from interviews with stakeholders
Focus groups: outcomes obtained from focus groups with stakeholders
Stakeholders Demand-side stakeholders: orthodontic patients and their family members
Supply-side stakeholders: clinicians, office staff, clinic owners, researchers, guideline
developers, policy makers, implant companies, etc.
Users/non-users: both demand- and supply-side stakeholders can be further subdivided
in those that have used OMIs previously (users) and those that have never used these
devices (non-users)
Interventions Specified interventions: these interventions refer to a specific phase or type of the
interventional procedure. Phases of the intervention refer to the anesthetics, implant
insertion, orthodontic treatment with OMIs, implant removal, or the healing phase.
Types of interventions refer to the implant type and dimensions, number of implants,
use of plates, the surgical procedure, implant location, timing and forces of orthodontic
loading, etc. [48].
“Non specified” interventions: these interventions refer to “any orthodontic treatment with OMIs.”
Additional information on the specific phase or type of the interventional procedure is not provided
Time points Pre-intervention recordings, i.e., recordings of outcomes prior to the interventional procedure
Immediate post-intervention recordings, i.e., recordings of outcomes within 2 weeks after the
completion of the interventional procedure
Long-term post-intervention recordings, i.e., recordings of outcomes more than 2 weeks after the
completion of the interventional procedure
Setting/country Private practice: stakeholders treated or working in a private practice
University setting: stakeholders treated or working in a university clinic
Country: stakeholders treated or working in a specific country
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 The prevalence of identified barriers and facilitators
among the surveyed or interviewed pertinent
stakeholders was calculated as follows:
Prevalence of an identified barrier or facilitator ¼
the number of stakeholders that scored
a particular construct as a barrier or facilitator to the
implementation of OMIs in clinical
practice=the total number of stakeholders that scored
on the role of this particular construct
as a barrier or facilitator to the implementation of
OMIs in clinical practice:
This prevalence was presented for example as 30/50.
 In our published protocol, we presented additional
information on (1) defining primary outcomes; (2)
the procedures to extract and categorize primary
outcomes; and (3) anticipated exemplary tables of
categorized implementation constructs [14, 38].
Secondary outcomes
 The secondary outcome was the prevalence of
clinicians that do not use OMIs and represents the
knowledge-to-action gap. This statistic was
calculated as follows:
The prevalence of clinicians that do not use OMIs ¼
the number of clinicians that do not use
OMIs=The total number of surveyed clinicians that
reported on the use of OMIs in clinical practice:
Information that could give further insights in the
understanding of the knowledge-to-action gap, e.g., the
number of implants placed per clinician per year, was
also recorded.
Risk of bias in individual studies
According to our protocol [14], we applied critical
appraisal instruments that were specific for the type of
research design used in the eligible studies. In this
review, we adopted The Joanna Briggs Institute critical
appraisal tool for quantitative studies that report preva-
lence and incidence data [35, 42, 59]. This instrument
has been specifically developed for questionnaires and
surveys. Differences between reviewers in scoring these
tools were resolved through discussions. A fourth
reviewer (NDG) was called upon in the case of disagree-
ment between reviewers. Authors of eligible studies were
contacted in the case of persistent disagreements on
appraisal scores.
The critical appraisal scores for each selected study
were listed in tables and for each appraisal tool separ-
ately [34, 35]. We calculated the prevalence of “yes”
scores (number of “yes”/number of articles) for each
individual appraisal question [42]. No attempts were
made to calculate overall appraisal scores. The potential
influence of each of the scored answers on the outcomes
of each selected study was weighted during the data
synthesis and was used to assess the overall strength of
evidence of the review (see “Confidence in cumulative
evidence”) [38]. Additional details on the procedures for
the assessment of risk of bias and the instruments for
assessing the methodological quality of studies were
presented in our published protocol [14].
Synthesis of results
Criteria for a quantitative synthesis
We only conducted meta-analyses for our primary and
secondary outcomes when (1) the risk of bias in the
eligible studies was low; (2) outcomes between studies
were consistent; (3) publication bias was low; (4) a high
number of studies was included; and (5) heterogeneity
was low [60–62]. Forest plots were used to display the
dispersion of the even rates of both primary and second-
ary outcomes. Comprehensive meta-analysis (CMA)
software was used to conduct all statistical analyses in
this systematic review [63, 64].
Unit-of-analysis issues and missing data
To deal with unit-of-analysis issues, we assessed whether
all participants underwent the same intervention, mul-
tiple interventions, and whether outcomes were re-
corded at different or multiple time points [61]. Our
strategies for dealing with missing data were presented
in our published protocol [14].
Qualitative synthesis
According to the PRISMA-P 2015 statement, we under-
took a systematic narrative (qualitative) synthesis even
when criteria for conducting quantitative syntheses were
fulfilled [38]. Our narrative synthesis was conducted
systematically and transparently to reduce the potential
for bias [65]. We refrained from vote counting, i.e.,
counting those studies that yielded a significant result
and those that did not [66, 67]. As suggested by the
PRISMA-P 2015 statement [38], we adopted the “estab-
lished methods” for conducting systematic narrative
syntheses according to the guidance of the Centre for
Reviews and Dissemination (CRD) [65]. The CRD frame-
work for conducting such a synthesis consists of four
phases: (1) developing a theory why and how each
barrier or facilitator could affect the implementation of
OMIs for each linked stakeholder; (2) developing an
initial synthesis of the findings of the eligible studies; (3)
exploring relationships within and between studies; and
(4) assessing the robustness of the synthesized evidence
[65]. These steps do not have to be conducted exactly
according to the order of this framework and were
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conducted iteratively by the three topic experts (RMR,
LR, LL) [65]. Disagreements were resolved through
discussions, and persistent disagreements were resolved
through the arbitrage of a fourth author (NDG) or
through contacting pertinent authors.
Risk of bias across studies
Meta-biases and confidence in the cumulative evidence
Meta-bias refers to the biased selection of research data
and covers both reporting bias (selective outcome
reporting) and publication bias [38]. Methods to assess
the presence and impact of both biases and strategies for
dealing with them were described in detail in our
published protocol [14, 54, 68–70].
For the assessment of the strength of the body of
evidence, we consulted the guidelines described by the
GRADE approach [71]. The robustness of the synthe-
sized evidence depends on (1) the number and size of
the eligible studies; (2) within and between study
diversity; (3) risk of bias assessments (magnitude and
direction); (4) the consistency of the outcomes between
studies; (5) the magnitude of the outcomes; and (6) the
presence of publication bias. To assess the robustness of
identified evidence we (1) weighed the role of these
variables; (2) revisited the data collection forms and the
critical appraisal tools to assess whether items have been
overlooked; and (3) contacted authors to obtain
additional information. We did not score the “levels of
evidence” according to the GRADE approach. Our
research questions do not qualify for this approach
because they do not address questions about interven-
tions, management strategies, or policies [72].
Additional analyses
Investigation of heterogeneity
We considered three sources of heterogeneity: methodo-
logical, clinical, and other sources of heterogeneity [61, 73].
These sources were selected a priori based on information
from previous systematic reviews on this research topic and
through discussions between the reviewers [45–48, 74].
Our “a priori” defined potential sources of heterogeneity
were listed in our published protocol [14]. The type of
stakeholders, i.e., patients, clinicians, and office staff, was
excluded as a source of diversity because outcomes were
analyzed separately for each type of stakeholder. We
reported when “post hoc” defined sources of heterogeneity
were investigated.
The presence of statistical heterogeneity was investigated
by calculating Cochran’s Q, the degrees of freedom based
on the number of eligible studies, and the pertinent p value
[64, 75–77]. We also calculated the following statistics:
Kendall’s τ2, τ, and I2 [64, 75, 77–80]. These calculations,
their use, and strategies for dealing with heterogeneity were
explained in our published protocol [14, 61].
Subgroup analysis, meta-regression, and sensitivity analysis
Our protocol described our planned methods for con-
ducting subgroup analyses, meta-regressions, and sensi-
tivity analyses [14]. Criteria, rationales, and caveats for
undertaking such research procedures were also outlined
in this protocol [61, 81, 82].
Contacting authors
Authors of pertinent primary research studies were
contacted to obtain additional information on (1) the
eligibility of specific research studies and (2) unclear or
missing data in primary research studies. The methods
for this research procedure were described in detail in
our published protocol [14].
Differences between the protocol and the review
We reported all changes in the methods during the
conduct of this research study compared with those
planned in the protocol. We described the type, timing,
and the rationale of each of these modifications. We also
reported the consequences of these changes on the direc-
tion, the magnitude, and the validity of the outcomes [83].
Results
Study selection
The outcomes of the searches of the various information
sources were summarized in a PRISMA flow diagram
(Fig. 1) [84]. A total of 18,021 records with overlap were
identified during the searching procedures. The retrieved
records for each data source together with the search
dates were listed in Additional file 2. We identified 37
articles, whose full texts were assessed for eligibility.
Three of these studies fulfilled the selection criteria. The
34 excluded articles with their references were listed
together with the rationale for their exclusion in
Additional file 3. Most of these studies were excluded
because patient health experiences or data on the use of
OMIs were recorded but not implementation constructs.
The selection procedures of eligible studies were
conducted in complete agreement between all three
reviewers.
Study characteristics
The characteristics of the three included studies were
summarized in Tables 2, 3, 4, and 5. Information
obtained through contacting authors was listed in red--
type face in these tables. All eligible studies were surveys
that used questionnaires as their research tools (Table 2).
All survey questions in the selected studies were closed-
ended, undefined, and not validated or pilot tested
(Table 2). Clinicians and patients were the only types of
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stakeholders that were surveyed in these studies (Table 3).
The sample sizes and the response rates of the included
studies varied widely. In the study by Zawawi [85], all (165/
165) surveyed stakeholders responded to questions on bar-
riers and facilitators (Table 3). In the studies of Meeran et
al. [8] and Bock and Ruf [5], the overall response rates of
the questionnaires were respectively 80.5 % (1691/2100)
and 47.9 % (1177/2459). Subpopulations of non-users of
OMIs in these latter studies were subsequently surveyed on
implementation constructs (Table 3). In the study by Bock
and Ruf [5], 84 of the 1177 questionnaires were excluded
because of missing or flawed information.
A total of 1556 stakeholders were surveyed on imple-
mentation constructs consisting of 165 patients [85] and
Fig. 1 PRISMA flow diagram of the study selection procedures [84]
Table 2 Characteristics of research methods
Items in black-type face represent those of the published manuscript. Items in red-type face represent those obtained through contacting the authors of the
pertinent manuscript
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1391 clinicians, i.e., 952 in Meeran’s [8] and 439 in
Bock’s and Ruf ’s study [5] (Table 3). Response rates on
implementation constructs were 100 % in the first two
studies [8, 85] and 78.6 % (345/439) in the latter article
[5]. Clarification on this latter prevalence was obtained
through contacting Dr. Bock [5]. The 165 patients in
Zawawi’s study [85] came from a university and a private
practice setting in Saudi Arabia and were mostly females
(113 females versus 52 males). Of these patients, 50.3 %
(83/165) needed orthodontic treatment with OMIs and
12.7 % (21/165) had heard of OMIs prior to completing
the questionnaires.
Questionnaires in Zawawi’s study [85] were compiled by
86.7 % (143/165) of the patients and by 13.3 % (22/165) of
the parents or siblings of patients (Table 4). In the survey of
Meeran et al. [8], 45.6 % (451/988) of clinicians in an urban
setting and 72.1 % (521/723) of clinicians in a semi-urban
or rural setting were the surveyed population of non-users
of OMIs (Table 4). Because the total of clinicians in the
different settings accounted for 1711 (988 + 723) stake-
holders, which differed from the total of 1691 respondents,
we asked the authors for clarification, but they did not
respond.
The members of the German Orthodontic Society that
were surveyed on implementation constructs in Bock
and Ruf ’s study [5] consisted of 439 non-users of OMIs,
which were divided in 417 strict non-users (non-users of
OMIs or osseointegrated palatal implants) and 22 users
of osseointegrated palatal implants [5]. Additional char-
acteristics on these stakeholders were listed in Table 4.
These characteristics were representative for the total
group (439) of non-users of OMIs and not for the 345
respondents of the non-users of OMIs. The type of
interventions was presented in Table 5. All included
studies defined the interventions with OMIs and
referred to “non specified interventions” indicating “any
type of orthodontic treatment with OMIs.”
Risk of bias within studies
We used the Joanna Briggs Institute critical appraisal
tool for studies that reported prevalence and incidence
data because all eligible studies were surveys [35, 59].
No major discussions between the three reviewers were
necessary to reach agreement on the appraisal scores.
These outcomes were listed in Table 6. The prevalence
of “yes” scores (number of “yes”/number of articles) for
each individual appraisal question was listed in this table
[42]. All eligible studies scored the same two appraisal
questions as “no.” None of these three studies used a
reference standard for assessing implementation con-
structs and serious confounding issues were identified in
all studies. The rationales for the appraisal scores were
described in Additional file 4, and all limitations of the
included studies were summarized in Table 7. The influ-
ence of the critical appraisal scores on the overall
strength of the evidence of this systematic review was
discussed in the section “Synthesis of results”.
Outcomes of individual studies
The three included studies identified a total of 17 imple-
mentation constructs, 13 for clinicians and 4 for patients
(Table 8). Fourteen of these constructs were barriers and
3 were facilitators. The prevalence of each barrier and
facilitator to the use of OMIs was also listed in Table 8.
The reporting of the numerators and denominators for
these statistics in the study by Bock and Ruf [5] was
Table 3 Response rates of surveyed populations and time points for completing questionnaires on implementation constructs
Items in black-type face represent those of the published manuscript. Items in red-type face represent those obtained through contacting the authors of the
pertinent manuscript
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unclear. We were able to confirm these numbers
through contacting Dr. Bock.
Only one included study surveyed patients on potential
implementation constructs [85]. This study identified three
facilitators (prevalence of 82.4 % (136/165), 86.7 % (143/
165), 90.9 % (150/165)) and 1 barrier (prevalence 65.5 %
(108/165)), to the use of OMIs (Table 8). The remaining
two studies identified a total of 13 barriers to the use of
OMIs for clinicians [5, 8] (Table 8). Three of these barriers
overlapped between both studies. This overlap could not be
assessed with 100 % certainty because none of the included
studies defined their questions on implementation con-
structs. Lack of training (67 % (638/952) and fear of risk
factors (54 % (514/952) were the two highest prevalence
statistics for barriers in Meeran’s study [8]. (Almost) no
suitable indications for OMIs 51 % (176/345) and skeptical
about success/failure rates of OMIs 56.2 % (194/345) were
the highest prevalence statistics for barriers in the study by
Table 4 Type of stakeholders surveyed on implementation constructs and their settings ab
Items in black-type face represent those of the published manuscript. Items in red-type face represent those obtained through contacting the authors of the
pertinent manuscript. For both the studies by Zawawi et al. (2014) [85] and Meeran et al. (2012) [8], these data are also representative for their responding
populations because response rates were 100 %. For the study by Bock et al. (2015) [5], these data were not representative for the responding population
because response rates were 78.6 % (345/439)
OPI osseointegrated palatal implant
aNumbers of non-users do not add up, i.e., 451 + 521 = 972 and not 952
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Bock and Ruf [5]. The remaining nine implementation con-
structs were all scored by 1/3 or less of the respondents.
Two [5, 8] of the included studies addressed our sec-
ondary research question on the use of OMIs (Table 9).
A total of 2784 (1691 + 1093) clinicians were surveyed
on this question. The prevalence of clinicians that do
not use OMIs was respectively 56.3 % (952/1691) [8]
and 40.16 % (439/1093) [5]. The prevalence of non-
urban non-users of OMIs, 72.1 % (521/723), was much
higher than the prevalence of urban non-users, 45.6 %
(451/988), in the study by Meeran et al. [8], but impreci-
sion was identified in reporting the numerators and
denominators (Table 9).
Risk of bias across studies (meta-biases)
Protocols of the included studies could not be found in
the literature, and we therefore contacted the authors on
this issue. Dr Zawawi [85] and Dr Bock [5] responded that
protocols were not registered or published. Risk of
selective outcome reporting was therefore assigned to these
studies. Dr. Meeran and his co-author, Dr Venkatesh, did
not respond to our questions [8]. Our assessments of publi-
cation bias were conditioned by the small number of eli-
gible studies for each identified implementation construct
[68]. Funnel plots were also not indicated for this reason.
Synthesis of results
Quantitative synthesis
Eleven of the 17 identified implementation constructs
were only found in single studies and therefore did not
qualify for a quantitative synthesis. The remaining 6
constructs overlapped between 2 studies [5, 8] and were
barriers to the implementation of OMIs for clinicians.
Although the prevalence statistics of these barriers
(clinician’s concerns regarding risks of using OMIs, clini-
cian’s concerns regarding indications of OMIs, clinician’s
concerns regarding the costs of OMIs) could be
summarized as pairs in meta-analyses, we decided not to
conduct such syntheses because (1) definitions of imple-
mentation constructs were not presented, and it was
therefore impossible to assess whether we were synthe-
sizing the same outcomes; (2) the number of included
studies was small (just two); (3) outcomes between
studies were inconsistent; (4) clinical and methodological
heterogeneity of the included studies was high or
unclear for numerous variables [60–62]; for example,
including users of osseointegrated palatal implants in
the non-users of OMIs group in the study by Bock and
Ruf [5] could have skewed outcomes; and (5) poor
reporting of a variety of issues (Tables 2, 3, 4, and 5) and
negative critical appraisal scores for at least two
appraisal criteria in all three included studies (Table 6)
Table 5 Type of interventions
Study Definition of interventions “Specified” or
“Non specified” intervention











Meeran 2012 [8] Reported Non specified intervention Not reported Not reported Not reported Not reported
Bock 2015 [5] Reported Non specified intervention Not reported Not reported Not reported Not reported
aOrthoEasy system (Forestadent, Pforzheim, Germany)
Table 6 Tabular presentation of the scores of the Joanna Briggs Institute critical appraisal tool of prevalence and incidence data [35, 59]a
Critical appraisal criteria for quantitative studies [35]: (1) Was the sample representative of the target population? (2) Were study participants recruited in an
appropriate way? (3) Was the sample size adequate? (4) Were the study subjects and the setting described in detail? (5) Was the data analysis conducted with
sufficient coverage of the identified sample? (6) Were objective, standard criteria used for the measurement of the condition? (7) Was the condition measured
reliably? (8) Was there appropriate statistical analysis? (9) Are all important confounding factors/subgroups/differences identified and accounted for? (10) Were
subpopulations identified using objective criteria? Critical appraisal scores: yes no unclear not applicable
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[35, 59]. To display these issues, we presented forests
plots and the heterogeneity statistics of these three imple-
mentation constructs in Tables 10, 11, and 12 [64]. We
used the fixed-effect model to display these plots because
it better represents the relative weights of the individual
studies than the random-effects model [86].
The prevalence data on the use of OMIs by the 2784 cli-
nicians in the studies by Meeran et al. [8] and Bock and Ruf
[5] were not synthesized in a meta-analysis for most of the
same reasons that were presented previously for implemen-
tation constructs (Table 13). Subgroup analyses and meta-
regression were not conducted to explore heterogeneity or
to address questions about specific stakeholders, interven-
tions, or study designs because only two studies [5, 8] were
included and data for the analysis of subgroups were not
given by the authors of these studies [61].
Qualitative synthesis and the robustness of the
accumulative evidence
According to our protocol, we synthesized the findings
exclusively in a narrative (qualitative) format because the
criteria for conducting quantitative syntheses (see previous
Table 7 Limitations of the included studies
Study Limitations of the included studies
Zawawi 2014 [85] • No published or registered protocol of the research study (risk of selective reporting)
• The research design (survey)
• Questionnaires with only closed-ended questions
• Mostly non-defined questions
• No pilot testing of research procedures
• No reference was made to a reference standard for assessing implementation constructs.
Survey instruments were not validated
• Unclear selection procedures but were clarified through contacting the author
• Unclear whether the answers of parents and siblings (13.3 % of the respondents) were
representative for those of the stakeholders
• The surveyed population was recruited from 2 different settings
• Prior knowledge on OMIs of 12.7 % (21/165) of respondents
• Additional unclear issues in Tables 2, 3, 4, and 5 and among the critical appraisal
scores (Additional file 4)
Meeran 2012 [8] • No published or registered protocol of the research study (risk of selective reporting)
• The research design (survey)
• Questionnaires with only closed-ended questions
• Mostly non-defined questions
• No pilot testing of research procedures
• No reference was made to a reference standard for assessing implementation constructs.
Survey instruments were not validated
• Unclear selection procedures
• Summing the total numbers of respondents in the different settings does not add up
to the total number of respondents referred to in other parts of the results
• The surveyed population was recruited from 2 different settings and were not equally
distributed. Urban respondents were overrepresented in the total sample and had less non-users
of OMIs compared with the non-urban population. This issue could have skewed outcomes
• Additional unclear issues in Tables 2, 3, 4, and 5 and among the critical appraisal
scores (Additional file 4)
Bock 2015 [5] • No published or registered protocol of the research study was identified (risk of selective reporting)
• The research design (survey)
• Questionnaires with only closed-ended questions
• Mostly non-defined questions
• No pilot testing of research procedures
• No reference was made to a reference standard for assessing implementation constructs.
Survey instruments were not validated
• Unclear terminology in the questionnaire had created confusion among respondents on the correct
interpretation of questions. This misunderstanding could have resulted in an overestimation of all
around users and OPI-only users and therefore an underestimation of MSC-only users, but this
issue did not affect our populations of interest
• The numerators and denominators were not completely clear in the published article and were
confirmed through contacting the authors of this research study
• Both strict non-users of OMIs and users of osseointegrated palatal implants were included among
the respondents, i.e., 417 (95 %) strict non-users of OMIs and 22 (5 %) osseointegrated palatal
implants users. Only strict non-users of OMIs would have been our preferred target population
• Various types of experience among subgroups of non-users of OMIs
• The 439 non-users were adequately described, but the characteristics of the 345 respondents on
implementation constructs of these 439 non-users were not described
• The response rate of the non-users of OMIs was 78.6 % (345/439). The rationale and the consequences
of this dropout were not described
• Additional unclear issues in Tables 2, 3, 4, and 5 and among the critical appraisal scores (Additional file 4)
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chapter) were not met for both the primary and secondary
outcomes [14]. Seventeen constructs (with three overlap-
ping) for the implementation of OMIs in clinical practice
were identified in 3 eligible studies. These constructs were
mostly self-explanatory but were not defined in any of
these articles. One study [85] surveyed patients as stake-
holders on potential barriers and facilitators to the use of
OMIs. The high prevalence statistics of all four identified
implementation constructs in this study demonstrated the
importance of these items among patients (Table 8). A
total of 13 barriers to the use of OMIs were identified for
clinicians in two of the included studies [5, 8] (Table 8).
Four of these barriers, i.e., (1) lack of training; (2) fear of
risk factors like root damage and infection; (3) (almost) no
suitable indications; and (4) skeptical about success/failure
rates of OMIs, were scored by more than 50 % of the
responding clinicians. The remaining nine barriers were
scored by 33.3 % or less of these stakeholders. Three of
Table 8 Barriers and facilitators to the implementation of OMIsa
a
Items in black-type face represent those of the published manuscript. Items in red-type face represent those obtained through contacting the authors of the
pertinent manuscript
aThe numerators and denominators were not completely clear in the published article and were confirmed through contacting the authors of this research study
bBarriers 6 and 15, 8 and 11, and 10 and 17 overlap
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the 13 barriers in these studies overlapped [5, 8] (Table 8).
The prevalence statistics of these overlapping barriers var-
ied widely between the two studies (Tables 10, 11, and 12).
The robustness of the accumulative evidence on these
three implementation constructs was conditioned by:
(1) the research design of the included studies
(surveys); (2) the small number of eligible studies; (3)
the limitations of the individual studies such as not de-
fining or describing the research questions (the primary
outcomes), using questionnaires with only closed-
ended questions, not pilot testing of research proce-
dures, using not-validated survey instruments (Tables 2,
3, 4, 5, 6, and 7 and Additional file 4); (4) the hetero-
geneity within and between studies such as differences
in surveyed populations; and (5) the risk of reporting
bias because protocols were not registered or published.
These variables also downgraded the validity of the
outcomes of these studies and significantly reduced
their applicability to different contexts. The use of
surveys as the research design and the exclusive use of
non-defined closed-ended questions in these studies were
key components for this downgrade.
The prevalence of clinicians that do not use OMIs in
the two eligible studies that addressed our secondary
research question was respectively 56.3 % (952/1691)[8]
and 40.16 % (439/1093) [5]. The validity of these
prevalence data was conditioned by many of the same
limitations that were also identified for the primary
research question.
Contacting authors
Our proceedings for contacting authors and our ques-
tions for these stakeholders as well as their answers were
presented in Additional file 5. Authors of two [5, 85] of
the three included articles replied within 1 day to our
“willingness to reply email” and subsequently addressed
all our questions. Exchange of data was conducted in a
positive and friendly context with both researchers.
Their answers clarified various issues on their research
studies and these issues were incorporated in Tables 2,
3, 4, 5, 6, 7, and 8. For example, Dr. Bock confirmed the
numerators and denominators for the prevalence statis-
tics of the implementation constructs. This information
allowed us to quantify these constructs and to include
them in forest plots (Tables 8, 9, 10, 11, and 12). The
reference author and one of the co-authors of the third
article [8] did not answer to our questions on their study
(Additional file 5).
Differences between protocol and review
All research proceedings in this systematic review were
conducted according to our published protocol [14].
Discussion
Summary of main findings
No earlier systematic review had addressed our research
questions. Three eligible studies were identified that
addressed these questions. Prior to conducting this
systematic review, three of the reviewers (RMR, LL, LR)
Table 9 Use of OMIs by clinicians
Study Overall response rate to questionnaires Prevalence of clinicians that do not use OMIs Subgroup of non-users of OMIs
Meeran 2012 [8] 80.5 % (1691/2100) 56.3 % (952/1691) Urban non-users, 45.6 % (451/988)a
Non-urban non-users, 72.1 % (521/723)a
Bock 2015 [5] 47.9 % (1177/2459) 40.16 % (439/1093)b
aThe numerators and denominators of non-users do not add up in the study by Meeran et al. (2012 [8]). Numerators, 451 + 521 = 972 and not 952. Denominators,
988 + 723 = 1711 and not 1691
bEighty-four of the 1177 questionnaires were excluded because of missing or flawed information. Therefore, only 1093 records were included
Table 10 Prevalence of clinicians that are concerned regarding the risks of using OMIs
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created a list of potential barriers and facilitators to the
implementation of OMIs in clinical practice. All 17
implementation constructs identified in the 3 eligible
studies were also found in this list. These constructs were
extracted from a total of 165 patients (Zawawi 2014) [85]
and 1391 clinicians (952 (Meeran et al. 2012) [8] and 439
(Bock and Ruf 2015)[5]. Eight of the 17 identified barriers
and facilitators were scored by more than 50 % of the
pertinent stakeholders, which showed the importance of
these constructs for these subjects (Table 8).
Our secondary research question was addressed by two
of the eligible studies, which showed that respectively
56.3 % (952/1691) (Meeran et al. 2012) [8] and 40.16 %
(439/1093) (Bock and Ruf 2015) [5] of clinicians do not
use OMIs (Table 9). These high-prevalence statistics
represented the knowledge-to-action gap and confirmed
the need for asking our primary research question. These
outcomes reflected the underuse of OMIs reported in
several other studies [6, 7, 19] but were much better than
those recorded by Banks et al. [4]. This latter survey was
conducted in 2010 and found that 99.8 % (608/620) of
British orthodontists do not use OMIs [4]. The validity
and the applicability of the findings for our primary and
secondary research questions were conditioned by a series
of limitations that are discussed in the following sections.
Limitations of the findings
The validity and the applicability of the findings of the
primary research question of this systematic review should
be considered in the context of the following variables: (1)
the small number of eligible studies; (2) not defining or
describing the research questions, i.e., the primary out-
comes; (3) the research design (surveys) of the identified
studies and the type of questions used; (4) the lack of pilot
testing of research methods; (5) the various specific limita-
tions within the selected studies (Tables 2, 3, 4, 5, 6, and 7
and Additional file 4); (6) heterogeneity between the
studies; and (7) the risk of reporting bias.
The small number of identified eligible studies was an
important limitation of the research findings of this
Table 11 Prevalence of clinicians that are concerned with the limited indications for OMIs
Table 12 Prevalence of clinicians that are concerned with the costs of OMIs
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systematic review. Verification of the research out-
comes of the eligible studies was difficult because only
one study [85] assessed implementation constructs for
patients and just two studies [5, 8] assessed these
items for clinicians. In addition, the questions for
these pertinent stakeholders were not defined in any
of these studies and mostly did not overlap. “The small
number of eligible studies” issue is particularly
important in the context of the numerous additional
shortcomings of the selected studies (Tables 2, 3, 4, 5,
6, and 7 and Additional file 4).
All included studies used surveys with closed-ended
questions as their research design, which impose import-
ant limitations: (1) feedback is only obtained on items
that are explicitly asked about and (2) the risk of asking
irrelevant and non-understandable questions [87]. These
limitations particularly apply to the surveys of Meeran et
al. [8] and Bock and Ruf [5].Other implementation con-
structs could have been more important than those sur-
veyed in these studies because only 33.3 % (2/6) [8] and
28.6 % (2/7) [5] of barriers were scored by more than
50 % of the respondents. Poor understanding of survey
questions was a major shortcoming of the study by Bock
and Ruf [5]. Unclear definitions of OMIs and osseointe-
grated palatal implants had created misunderstanding
among respondents in this study and could have flawed
outcomes. Focus groups and in-depth interviews can be
used to deal with these limitations of surveys. They can
be conducted as pilot tests during the development of
the survey questionnaires to identify possible implemen-
tation constructs and their importance. None of the
included studies undertook such investigations nor
pilot tested their research methods. In addition, none
of these studies searched the literature to identify
tested and validated standards for asking research ques-
tions on implementation constructs. Using new poorly
defined questions is problematic when (1) interpreting
and applying answers of respondents; (2) testing the
reproducibility of answers; and (3) findings are included
in a meta-analysis.
Numerous additional limitations were identified in the
selected studies (Tables 2, 3, 4, 5, 6, and 7 and
Additional file 4). Variables that could have influenced
outcomes in Zawawi’s study [85] refer to including (1)
respondents with and without prior knowledge on the
interventional procedure with OMIs; (2) both patients and
parents or siblings as respondents; and (3) respondents
from different settings with possibly different characteris-
tics (Table 7). Including patients that did and did not
need OMIs in the survey was not an issue because
these stakeholders were not informed about this treat-
ment option prior to completing the questionnaires.
This information and the fact that all patients were
consecutively treated were obtained through contacting
the authors (Additional file 5).
Outcomes in Meeran’s study [8] could be influenced
by additional factors such as (1) the type of selection
procedures of the 2100 enrolled orthodontists; (2) un-
clear reporting on response rates, i.e., numbers did not
always add up (Tables 2, 4, and 9); and (3) urban respon-
dents were overrepresented in the total sample and
consisted of less non-users of OMIs than clinicians
practicing in non-urban settings (Tables 2, 4, and 7 and
Additional file 4). The importance of these issues could
not be verified because both the author and a co-author
did not reply to our questions (Additional file 5).
Additional variables that could have influenced outcomes
in the study by Bock and Ruf [5] were (1) unclear termin-
ology in the questionnaire; (2) including both strict non-u-
sers of OMIs and users of osseointegrated palatal implants
as respondents on implementation constructs for OMIs.
However, this latter subgroup of non-users consisted only
of 5 % (22/439) of the total population of non-users of
OMIs; (3) various types of experience with OMIs among
the subgroups of non-users of OMIs; (4) the characteristics
of the 439 non-users of OMIs was described but not those
Table 13 Prevalence of clinicians that do not use OMIs
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of the 345 respondents on implementation constructs. The
rationale and the consequences of the dropout of the 94
non-responders was not discussed; and (5) various report-
ing issues (Tables 2, 5, 6, and 7 and Additional file 4).
Sources of heterogeneity between the selected studies
included (1) the study design and size; (2) the characteris-
tics of the respondents; (3) the type of interventions; (4) the
setting and country; and (5) additional within study limita-
tions that were outlined above. Heterogeneity was clearly
depicted in the three forest plots of overlapping barriers to
the implementation of OMIs and was confirmed by its
statistics (Tables 10, 11, and 12). None of the studies had
published or registered a protocol of their research study,
which could have introduced reporting bias.
Identifying and quantifying implementation constructs
and dealing with them
The identification and quantification of barriers and facili-
tators to knowledge use are key for a successful knowledge
translation plan [58, 88, 89]. High-prevalence statistics
(>65 %) were identified for four implementation con-
structs for patients indicating their importance for these
stakeholders [85] (Table 8). Patient-mediated implementa-
tion strategies can be developed to deal with these con-
structs. Such strategies could focus on informing patients
and the wider public on the potential advantages of OMIs,
for example, shorter treatment times, better treatment
outcomes, less extractions, and that OMIs are the only
options to obtain certain results [85]. Successful know-
ledge translation to these stakeholders could be obtained
through: educational materials, financial incentives, con-
sultations to explain the interventional procedure and its
evidence base, videos of patients that have already under-
gone treatment with OMIs, and meetings with such stake-
holders [89]. Informing patients on qualitative outcomes
such as acceptance of the use of these devices and the as-
sociated pain and discomfort could be an important strat-
egy to facilitate the implementation of OMIs [90–96]. In
this context, it should be noted that Zawawi’s study [85]
showed that the large majority, 91.6 % (76/83), of subjects
that were surveyed after the insertion of OMIs recom-
mended this treatment to others. This finding is congru-
ent with other studies that assessed this issue [92, 95, 96].
Thirteen barriers to the use of OMIs were identified
for clinicians in two of the selected studies [5, 8]. Three
of these constructs overlapped (Tables 10, 11, and 12).
Four barriers were scored by more than 50 % of the
surveyed clinicians in these studies: (1) lack of training
[8]; (2) fear of risk factors [8]; (3) (almost) no suitable
indications [5]; and (4) skepticism about the success/
failure rates of OMIs [5]. Strategies for dealing with
these barriers could include printed educational mate-
rials, e.g., up-to-date syntheses and clinical practice
guidelines [25], educational meetings, in particular
small meetings with a particular topic [97], educational
outreach, e.g., invitation of a clinical expert [98], opin-
ion leaders [99], audit and feedback [100, 101], hands-
on training, financial incentives, knowledge manage-
ment interventions such as “evidence-based healthcare”
training courses, peer meetings, and a variety of other
tailored strategies [102]. Skepticism of clinicians about
the success/failure rates of OMIs could also be the re-
sult of the low or moderate quality of research findings
on OMIs that was identified in numerous systematic re-
views and critical appraisals of articles on these devices
[9, 11, 45, 46, 48, 103, 104]. Improving the quality of re-
search studies on OMIs could be key in addressing his
issue.
The effectiveness and efficiency of many of the
presented knowledge translation interventions are not
always well understood [89, 105, 106]. Choosing a know-
ledge translation intervention or a combination of them is
both a “science” and an “art” [25, 107].
Strengths and limitations of this systematic review
The strengths of this research study include (1) it was
the first systematic review that addressed these research
questions; (2) a protocol was submitted and published
prior to applying the research methods of this systematic
review, which reduced the risk of reporting bias [14]; (3)
literature searches were conducted with broad-spectrum
search strategies in a wide variety of databases and
without language restrictions [53]; (4) data extraction ta-
bles were presented in great detail and were pilot tested;
(5) this study was conducted independently by experi-
enced systematic reviewers, methodologists, and topic
experts, who had published several systematic reviews
and review protocols on OMIs [14, 45–48]; (6) transpar-
ent reporting of all research proceedings in both the
protocol and the final manuscript of this systematic
review; and (7) authors were contacted by reviewers
to obtain additional research data. These latter re-
search procedures were used to verify reporting issues
and to obtain additional research data. For example
prevalence statistics of implementation constructs
were clarified in the study by Bock and Ruf [5], which
permitted the depicting of some of these statistics in
forest plots and explore statistical heterogeneity
(Tables 10, 11 and 12). The weaknesses of this
systematic review were outlined previously in the
section ‘Limitations of the findings’.
Why these findings are important and for who
Notwithstanding the limitations of this systematic
review, its findings are important because:
(1) Seventeen barriers and facilitators were identified of
which 8 were scored by more than 50 % of the
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surveyed stakeholders, demonstrating the
importance of these implementation constructs.
(2) The limitations and the small number of the eligible
studies showed the need for additional studies on
this research topic. The exclusive use of non-pilot
tested, and non-defined closed-ended questions and
not consulting potentially existing standards for
exploring implementation constructs were key
limitations of the included studies.
(3) Of the high underuse of OMIs, which was
confirmed by two [5, 8] of the selected studies
which showed the severity of the knowledge-into-
action gap. The problem of underuse of OMIs is
probably more dramatic, because we only recorded
the prevalence statistic of clinicians that do not use
these devices. However, several forms of underuse of
OMIs by clinicians exist: (1) never having used OMIs;
(2) having used OMIs and stopped using them; and
(3) using them infrequently. These three types of
subgroups of underusers of OMIs should be
considered separately in future research studies.
For example Bock and Ruf [5] showed that only 1 %
(4/417) of the users of OMIs used these devices on
more than 2 patients per week, but most clinicians,
i.e., 68.5 % (286/417), used OMIs infrequently (≤2
new patients/quarter). Underuse of OMIs among
users was also recorded in other surveys [6, 18–20].
The underuse of OMIs was unexpected from a
patient’s perspective, because most patients
recommend interventions with OMIs to others
[85, 92, 95, 96]. This underuse of OMIs was also
unexpected from a clinician’s perspective, because of
the numerous publications on their promising
success rates, effectiveness, and wide applicability
[9–11] and because they were included in the
treatment plan for a common orthodontic patient by
more than 75 % of 108 surveyed doctors [21].
Zawawi [85] indicated OMIs in 50.3 % (83/165) of
consecutively treated patients.
The identification and quantification of the 17 imple-
mentation constructs and the high underuse of OMIs in
clinical practice could be important rationales to redirect
research studies of OMIs towards implementation issues.
Wasting less research money and improving the quality
of orthodontic treatment could be the consequence
[108]. The findings of this systematic review are import-
ant for patients, clinicians, researchers, policymakers, in-
surance companies, implant companies, and research
sponsors.
What is next?
Future research should continue to focus on identifying
and quantifying barriers and facilitators to the use of
OMIs in clinical practice because this information is key
to a successful knowledge translation plan [58, 88, 89].
The limitations of the included studies in this systematic
review could be important items to consider when
developing future studies. Conducting qualitative and
quantitative systematic reviews of patient health experi-
ences with OMIs is an essential initial step for evidence-
based knowledge creation on implementation constructs.
However, strategies to identify such constructs do not
only include systematic reviews and surveys but also
refer to (1) focus groups; (2) in-depth interviews; (3) talk-
ing to key individuals on the interventional procedures,
e.g., clinical experts or guideline developers; (4) observing
of the interventional procedure in action, e.g., in a clinical
practice setting; and (5) brainstorming [25, 89]. These five
methods can also be used as pilot tests or to fine-tune
research questions for future survey questionnaires on
implementation constructs. When such constructs are
identified, tailored stakeholder-specific strategies can be
developed to deal with them.
Conclusions
This is the first systematic review that addressed imple-
mentation issues of OMI in clinical practice. The three
eligible surveys [5, 8, 85] identified and quantified 17
implementation constructs. Three facilitators and one
barrier (costs) were identified by more than 60 % of the
orthodontic patients [85]. Lack of training, fear of risk
factors, (almost) no suitable indications, and skepticism
about additional benefit of OMIs were identified as
barriers to the implementation of OMIs by more than
50 % of orthodontic clinicians [5, 8].
The main limitations of these studies included (1) the
small number of studies; (2) not defining the research
questions, i.e., the primary outcomes; (3) the research de-
sign (surveys) of the studies and the exclusive use of
closed-ended questions; (4) not consulting standards for
identifying implementation constructs; (5) the lack of pilot
testing; (6) high heterogeneity; (7) the risk of reporting
bias; and (8) additional shortcomings. This leaves much
space for the exploration of additional constructs through
open-ended questions in other research designs, such as
in-depth interviews or focus groups. The severe underuse
of OMIs that was identified in the selected studies demon-
strated the need to identify and quantify such constructs
and to develop strategies to deal with them.
Most primary studies on OMIs have addressed
variables associated with their stability and effectiveness
and few studies have assessed factors associated with
their implementation. This study showed the need to
change course. Before undertaking new research studies
on OMIs, it will be necessary to consult the findings of
this systematic review and other reviews and convene a
Meursinge Reynders et al. Systematic Reviews  (2016) 5:163 Page 18 of 21
variety of stakeholders, such as patients, clinicians, re-
searchers, government bodies, guideline developers, and
implant companies, to develop priority questions in this
field of research [109]. Prioritizing such questions could
redirect research on OMIs towards studies on their im-
plementation. This could reduce additional research
waste and benefit patients, clinicians, researchers, policy-
makers, insurance companies, implant companies, and
research sponsors [108].
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